
Sign up to save your podcasts
Or


Send us a text
In this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and analyst Robert Sassoon talk with Apyron CEO Jaggi Gill about the company's innovative neurostimulation technology for chronic pain, an all too prevalent affliction affecting millions of people. Gill explains why Apyron’s patient-focused approach stands out, and outlines the market opportunity and commercialization strategy.
By Water Tower Research5
88 ratings
Send us a text
In this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and analyst Robert Sassoon talk with Apyron CEO Jaggi Gill about the company's innovative neurostimulation technology for chronic pain, an all too prevalent affliction affecting millions of people. Gill explains why Apyron’s patient-focused approach stands out, and outlines the market opportunity and commercialization strategy.

228,897 Listeners

3,212 Listeners

3,377 Listeners

1,283 Listeners

9,552 Listeners

1,204 Listeners

9,444 Listeners

112,321 Listeners

2,025 Listeners

1,046 Listeners

196 Listeners

10,017 Listeners

248 Listeners

1,428 Listeners

20 Listeners